Exploring the Future: Frontier Technologies Forge Ahead — Gene Sequencing Innovation Forum

Gene sequencing technology is a foundational technique in the life sciences. Gene sequencing (DNA Sequencing) refers to the technology used to determine the nucleotide sequence of target DNA fragments. In basic biological research, as well as in an ever-expanding range of other application fields—including medical diagnostics, biotechnology development, forensic biology, systems biology, and microbiology—gene sequencing has become one of the most critical specialized technologies.

With the release of the “14th Five-Year Plan for Bioeconomy Development” and the accelerated translation of technologies such as gene sequencing and biological computing, we are currently ushering in the best historical opportunity period for the development of health undertakings and biotechnology, bringing excellent opportunities for technological translation and enterprise development. In particular, the gene industry leverages interdisciplinary approaches and cutting-edge technologies to decipher the mysteries of life science, serving the construction of a Healthy China and the development of the bioeconomy. Currently, the size of China’s gene sequencing market was $1.59 billion in 2021, accounting for 10.13% of the global market; it is expected to grow to $4.235 billion by 2026, representing 11.23% of the global market.

The 2023 Future Healthcare Technology Conference will systematically review the 30 most noteworthy cutting-edge technologies in the life and health sector, with gene sequencing featured as one of the top 30 forward-looking technologies. The forum invites research scholars, industry experts, and investors from the gene sequencing field to share insights on emerging technological trends, as well as explorations and reflections on practical applications, guiding innovators in China’s healthcare sector to venture into the “uncharted territory” of medical technology.